ZNF35 and neoplasm: Intratumoral administration of the herpes simplex virus HF10 has been studied in patients with recurrent head and neck squamous cell carcinoma and it has been shown that HF10 replicated, distributed well in the tumor nodules and resulted in cell death in a major population of tumor cells, with no significant adverse effects [99].